Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Hematology · Chronic Myelomonocytic Leukemia

Can Diet, Exercise, or Supplements Treat CMML? What to Know

At a Glance

No diet, exercise routine, or supplement has been shown to slow or cure CMML. Nutrition and appropriately adjusted physical activity can support strength and quality of life, but supplements may cause bleeding or drug interactions and should be reviewed with the care team.

In this answer

3 sections

01

Nutrition and Food Safety

02

Exercise: Staying Active Safely

03

The Hidden Risks of Supplements

No diet, supplement, exercise routine, or complementary treatment has been shown to slow the progression of chronic myelomonocytic leukemia (CMML), eliminate the leukemia cells, or replace standard medical treatment [1][2]. Currently, the only treatment with the potential to cure CMML is an allogeneic stem cell transplant (a procedure using stem cells from a donor). However, this procedure is not an option for everyone and carries substantial risks [3]. Standard medications, such as hypomethylating agents, are used to control the disease and manage symptoms, though they are generally not curative [4].

While lifestyle changes cannot cure CMML, they play a vital role in your supportive care. Tailored nutrition and physical activity can help you maintain strength, manage treatment side effects, and improve your quality of life.

When to Call Your Care Team Immediately

Do not exercise or wait for a scheduled appointment if you experience signs of an emergency. Contact your care team or seek immediate medical care if you develop:

  • A fever (usually 100.4°F or 38.0°C and above, but ask your team for your specific emergency threshold)
  • Uncontrolled bleeding, new severe bruising, or black, tarry stools
  • Fainting or severe dizziness
  • New or worsening chest pain or severe shortness of breath
  • A fall or head injury

Nutrition and Food Safety

While no specific dietary pattern (like fasting or alkaline diets) can treat leukemia, good nutrition is a critical part of supportive care [2]. Blood cancers can increase the risk of cachexia (a disease-driven wasting syndrome that causes weight and muscle loss) and sarcopenia (reduced muscle strength and mass) [5]. These conditions are linked to poorer survival and a lower tolerance for treatments [6][5]. Because cachexia is driven by inflammation from the disease, it cannot always be reversed just by eating more calories, making early dietitian support essential.

  • Practical Steps: Eating small, frequent meals and choosing protein- and calorie-dense foods can help you maintain strength [7][8]. CMML and its treatments can cause nausea or decreased appetite [9][10]. Ask if a clinician-approved oral nutrition drink might help.
  • Food Safety: If your white blood cells are low, or if you are preparing for a transplant, safe food handling is critical to prevent infection [11]. Wash your hands frequently, avoid raw or undercooked meats, and wash produce thoroughly. Your team will tell you if you need to follow specific transplant-center food guidelines.

Exercise: Staying Active Safely

Staying physically active helps combat fatigue, preserves muscle function, and improves quality of life [12]. However, because CMML causes cytopenias (low blood-cell counts), your physical activity must be carefully tailored to your specific lab results [13][14]. Ask your team for personalized guidelines based on your blood counts, enlarged spleen, or whether you have a central line:

  • Anemia (Low Red Blood Cells): Causes severe fatigue, dizziness, and shortness of breath [13]. When your hemoglobin is low, you may need to focus on light activities and take frequent rest breaks to prevent falls.
  • Thrombocytopenia (Low Platelets): Increases your risk of bruising and bleeding [13]. Your doctor may advise avoiding contact sports, heavy lifting, or activities with a high fall risk, depending on your exact platelet count.
  • Neutropenia (Low Neutrophils): Neutrophils are the specific white blood cells that fight bacterial infections [14][15]. Severe neutropenia may require you to avoid crowded public gyms or pools, though this does not mean all physical activity is prohibited.

The Hidden Risks of Supplements

It is critical to review every supplement, vitamin, and herbal remedy with your oncology team and pharmacist. In many regions, including the United States, dietary supplements are not evaluated for safety and effectiveness like prescription medicines are. Always bring the actual bottles or photos of the labels (including the exact dose and brand) to your appointments.

  • Bleeding Risks: Some supplements—like highly concentrated garlic, ginkgo, ginseng, green tea extract, and fish oil—may increase bleeding risks [16][17]. This is especially dangerous if you have low platelets or take blood thinners. Culinary amounts used in regular cooking are generally safe, but concentrated extracts require medical review.
  • Drug Interactions: Botanical supplements can interfere with how your body processes cancer drugs [18]. For example, St. John’s wort causes clinically significant interactions and is generally avoided [19]. Turmeric supplements often contain piperine (black pepper extract), which can alter the metabolism of concurrent medications [20].
  • Organ Stress: The medical team will monitor your liver and kidney function, as CMML can occasionally cause kidney issues, and high doses of unregulated supplements can put extra stress on these organs [21].
  • Antioxidants: Very high-dose antioxidant supplements (like Vitamins A, C, or E) might interfere with how certain cancer therapies work [22][23]. Never start or stop a prescribed vitamin without consulting your clinician.

Complementary practices like acupuncture, massage, or yoga may help manage pain, anxiety, and fatigue [24][25][26]. However, they require clearance based on your current blood counts. For example, needles or deep-tissue massage can cause dangerous bleeding or infection if your platelets or white blood cells are low, and yoga may need modification if you are at risk for falls. Always use an appropriately trained practitioner alongside, not instead of, your standard medical care [27].

Common questions in this guide

Can changing what I eat cure or slow CMML?
No. No diet, fasting plan, supplement, exercise routine, or complementary therapy has been shown to slow CMML, eliminate leukemia cells, or replace standard treatment. Nutrition and activity can still support strength, symptom management, and quality of life.
What should I eat if CMML or treatment is affecting my appetite?
An oncology dietitian can help you choose small, frequent meals and protein- and calorie-dense foods when your appetite or weight is falling. A clinician-approved oral nutrition drink may help some people, but disease-related cachexia may not be reversed by simply eating more.
How can I exercise safely while living with CMML?
Many people can remain active, but the plan must match their blood counts and other risks. Low hemoglobin may require light activity and rest; low platelets may mean avoiding contact sports or fall risks; and low neutrophils may affect crowded gyms or pools.
Which vitamins or herbal supplements may be unsafe with CMML treatment?
Do not start a vitamin, herb, or supplement without asking your oncology team and pharmacist. Concentrated garlic, ginkgo, ginseng, green tea extract, and fish oil may increase bleeding, while St. John’s wort, piperine-containing turmeric products, and high-dose antioxidants may interact with medicines or treatments.
Can acupuncture, massage, or yoga help with CMML symptoms?
Acupuncture, massage, and modified yoga may help with pain, anxiety, or fatigue, but they do not treat the leukemia itself. Your care team should clear them first because needles or deep massage can cause bleeding or infection when counts are low, and yoga may need changes if you are at risk of falling.
What treatments can actually control or potentially cure CMML?
Currently, an allogeneic stem cell transplant is the only treatment with potential to cure CMML, but it is not suitable for everyone and has substantial risks. Hypomethylating agents can help control the disease and manage symptoms, but they are generally not curative.
When should I seek urgent medical help with CMML?
Contact your care team urgently or seek immediate medical care for a fever at or above the threshold your team gave you, often 100.4°F or 38°C, uncontrolled bleeding, black stools, fainting, new chest pain, severe shortness of breath, or a fall or head injury. Do not exercise while waiting for advice if these symptoms occur.

Related questions

How Do CMML Risk Scores Differ? CPSS-Mol, Mayo, iCPSS What Is CMML Life Expectancy and AML Risk by Group? Can a CMML Risk Score Change Over Time? What to Know Can Past Cancer Treatment or Chemical Exposure Cause CMML? Can I Work, Exercise, and Travel During CMML Treatment?
Show more
How Common Is CMML, and Who Develops This Blood Cancer? How Is CMML Progression to AML Detected by Doctors? How Do Doctors Tell Reactive Monocytosis From CMML? How Do Dysplastic CMML and Proliferative CMML Differ? How Is CMML Different From CML, MDS and Other Blood Cancers? How Long Must Monocytosis Last Before CMML Diagnosis? How Should I Interpret My CMML Risk Score Results? Is CMML Inherited? Should My Family Get Genetic Testing? What Causes CMML? Did I Do Anything to Cause My CMML? What Do CMML Chromosome and Mutation Tests Mean for You? What Is Monocyte Repartitioning Flow Cytometry for CMML? What Is the Difference Between CMML-1 and CMML-2? Treatment What Is the WHO vs ICC Difference in CMML Diagnosis? Why Do I Need a Bone Marrow Biopsy for CMML Diagnosis?

Get notified when new evidence is published on chronic monocytic leukemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (27)
  1. 1

    Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet.

    Itzykson R, Fenaux P, Bowen D, et al.

    HemaSphere 2018; (2(6)):e150 doi:10.1097/HS9.0000000000000150.

    PMID: 31723789
  2. 2

    Leveraging Dietary Interventions to Benefit Patients with Hematologic Malignancies and Clonal Hematopoiesis.

    Brzechffa C, Fleischman AG

    Nutrients 2026; (18(10)) doi:10.3390/nu18101562.

    PMID: 42197020
  3. 3

    Chronic myelomonocytic leukemia diagnosis and management.

    Chan O, Renneville A, Padron E

    Leukemia 2021; (35(6)):1552-1562 doi:10.1038/s41375-021-01207-3.

    PMID: 33714974
  4. 4

    Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia.

    Hunter AM, Zhang L, Padron E

    Current treatment options in oncology 2018; (19(12)):67 doi:10.1007/s11864-018-0581-6.

    PMID: 30367269
  5. 5

    An integrative review of cancer-related cachexia and sarcopenia: A different focus in malignant hematology.

    Tinsley-Vance SM, Mason TM, Komrokji RS

    Health sciences review (Oxford, England) 2024; (13()) doi:10.1016/j.hsr.2024.100205.

    PMID: 39802938
  6. 6

    Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation.

    Armenian SH, Xiao M, Berano Teh J, et al.

    Journal of the National Cancer Institute 2019; (111(8)):837-844 doi:10.1093/jnci/djy231.

    PMID: 30951603
  7. 7

    Are We Identifying Malnutrition in Hospitalized Patients with Hematologic Malignancies? Results from a Quality Clinical Audit.

    Kanioura E, Tzanninis IG, Poulia KA, et al.

    Diseases (Basel, Switzerland) 2022; (10(3)) doi:10.3390/diseases10030040.

    PMID: 35892734
  8. 8

    Nutrition Support Interventions in Adults with Hematologic Malignancies: A Systematic Review and Meta-Analysis.

    Newman R, Rozga M, Handu D, et al.

    Journal of the Academy of Nutrition and Dietetics 2026; (126(3)):156221 doi:10.1016/j.jand.2025.156221.

    PMID: 41761730
  9. 9

    Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study.

    Patnaik MM, Ali H, Wang ES, et al.

    Blood neoplasia 2025; (2(4)):100115 doi:10.1016/j.bneo.2025.100115.

    PMID: 40919483
  10. 10

    Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.

    Borthakur G, Popplewell L, Boyiadzis M, et al.

    Cancer 2016; (122(12)):1871-9 doi:10.1002/cncr.29986.

    PMID: 26990290
  11. 11

    Prevalence and Molecular Characterization of Cryptosporidium Species in Patients With Hematologic Malignancies in Eastern Iran.

    Solgi R, Mousavi SM, Saeedi S, et al.

    International journal of microbiology 2026; (2026()):3566454 doi:10.1155/ijm/3566454.

    PMID: 42205885
  12. 12

    Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.

    Sung AD, Koll T, Gier SH, et al.

    Transplantation and cellular therapy 2024; (30(4)):415.e1-415.e16 doi:10.1016/j.jtct.2024.01.062.

    PMID: 38242440
  13. 13

    A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.

    Santini V, Allione B, Zini G, et al.

    Leukemia 2018; (32(2)):413-418 doi:10.1038/leu.2017.186.

    PMID: 28607470
  14. 14

    Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.

    Abdulgayoom M, Afana MS, Saleh LH, et al.

    Acta haematologica 2026; 1-16 doi:10.1159/000551885.

    PMID: 41945493
  15. 15

    Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1-2 study.

    Bazinet A, Darbaniyan F, Jabbour E, et al.

    The Lancet. Haematology 2022; (9(10)):e756-e765 doi:10.1016/S2352-3026(22)00216-2.

    PMID: 36063832
  16. 16

    Commonly Used Dietary Supplements on Coagulation Function during Surgery.

    Wang CZ, Moss J, Yuan CS

    Medicines (Basel, Switzerland) 2015; (2(3)):157-185 doi:10.3390/medicines2030157.

    PMID: 26949700
  17. 17

    Warfarin and food, herbal or dietary supplement interactions: A systematic review.

    Tan CSS, Lee SWH

    British journal of clinical pharmacology 2021; (87(2)):352-374 doi:10.1111/bcp.14404.

    PMID: 32478963
  18. 18

    Clinically Relevant Herb-Drug Interactions: A 30-Year Historical Assessment.

    Gurley BJ

    Journal of dietary supplements 2025; (22(1)):78-104 doi:10.1080/19390211.2024.2327544.

    PMID: 38504455
  19. 19

    Common Herbal Dietary Supplement-Drug Interactions.

    Asher GN, Corbett AH, Hawke RL

    American family physician 2017; (96(2)):101-107.

    PMID: 28762712
  20. 20

    Curcuminoid Content and Safety-Related Markers of Quality of Turmeric Dietary Supplements Sold in an Urban Retail Marketplace in the United States.

    Skiba MB, Luis PB, Alfafara C, et al.

    Molecular nutrition & food research 2018; (62(14)):e1800143 doi:10.1002/mnfr.201800143.

    PMID: 29808963
  21. 21

    Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease.

    Lafargue MC, Bobot M, Rennke HG, et al.

    Kidney international reports 2023; (8(12)):2733-2741 doi:10.1016/j.ekir.2023.09.005.

    PMID: 38106568
  22. 22

    Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).

    Ambrosone CB, Zirpoli GR, Hutson AD, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(8)):804-814 doi:10.1200/JCO.19.01203.

    PMID: 31855498
  23. 23

    Dietary supplement use and recommendations for discontinuation in an integrative oncology clinic.

    D'Andre SD, Bauer BA, Hofmann MB, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022; (31(1)):40 doi:10.1007/s00520-022-07504-6.

    PMID: 36525104
  24. 24

    Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline.

    Mao JJ, Ismaila N, Bao T, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022; (40(34)):3998-4024 doi:10.1200/JCO.22.01357.

    PMID: 36122322
  25. 25

    Integrative Therapies in Cancer Care: An Update on the Guidelines.

    Gowin K, Muminovic M, Zick SM, et al.

    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2024; (44(3)):e431554 doi:10.1200/EDBK_431554.

    PMID: 38820485
  26. 26

    Yoga as a Complementary Therapy for Cancer Patients: From Clinical Observations to Biochemical Mechanisms.

    Blockhuys S, Wittung-Stafshede P

    Complementary medicine research 2024; (31(5)):403-415 doi:10.1159/000540213.

    PMID: 38991506
  27. 27

    Evidence-Based Perspectives on Complementary and Alternative Medicine in Cancer Treatment: Current Advances and Clinical Relevance.

    Wali AF, Talath S, Alaani NN, et al.

    Journal of multidisciplinary healthcare 2026; (19()):629362 doi:10.2147/JMDH.S629362.

    PMID: 42699264

This page is for informational purposes only and does not constitute medical advice. Your hematology or oncology team should guide nutrition, activity, supplements, and urgent-care decisions based on your blood counts and treatment.